Research & Analysis

Takeda launches CINRYZE™ in India, the first C1-I NH for prophylaxis in hereditary angioedema patients

Takeda, a global values-driven, R&D focused biopharmaceutical leader has launched Cinryze; an innovative injectable prescription medicine for the treatment of hereditary angioedema (HAE) patients. The medication is effective on HAE patients between 2-6 years above of age and…




G20 Development Working Group Meeting in Mumbai Day1

MUMBAI, 13 DECEMBER, 2022 (GPN): The first meeting of the Development Working Group (DWG) under India’s G20 Presidency is currently underway in Mumbai. Members, Guest countries and invited International Organizations are attending the meeting in…







HGH India – Country’s most popular trade show for HOME and HOUSEWARE segment commences its 12th edition at Bombay Exhibition Center, Mumbai

With a 20% increase in y-o-y demand, India now ahead of China by several International brands Will sustain 15% growth in a conservative scenario | Can go up to 30% in some categories MUMBAI, 13th…